Skip to main content
Clinical Trials/NCT02362126
NCT02362126
Unknown
Not Applicable

Endoscopic Full Thickness Resection in the Lower GI Tract With the "Full Thickness Resection Device"- A Prospective Multicenter Trial

Kliniken Ludwigsburg-Bietigheim gGmbH1 site in 1 country80 target enrollmentFebruary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Adenomas
Sponsor
Kliniken Ludwigsburg-Bietigheim gGmbH
Enrollment
80
Locations
1
Primary Endpoint
Technical success
Last Updated
11 years ago

Overview

Brief Summary

Observational prospective multicenter study to investigate efficacy and safety of endoscopic full thickness resection in the lower GI tract using a novel over-the-scope full thickness resection device.

Detailed Description

The FTRD ("Full Thickness Resection Device", Ovesco Endoscopy, Tübingen, Germany) is an over the scope device consisting of a transparent cap with a preloaded monofilament snare and and a 14 mm modified Over-the-scope Clip. The device is CE marked for full thickness resection in the lower GI tract. The study was designed to investigate efficacy and safety of this device for full thickness resection of colorectal lesions.

Registry
clinicaltrials.gov
Start Date
February 2015
End Date
February 2017
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kliniken Ludwigsburg-Bietigheim gGmbH
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 y
  • Adenoma with negtive lifting sign
  • Adenoma involving or next to a diverticulum
  • Adenoma involving or next to the appendical orifice
  • T1 carcinoma with indication for endoscopic (re-)resection
  • Subepithelial colorectal tumor with indication for resection

Exclusion Criteria

  • Lesions \>3 cm
  • T1 carcinomas with known high-risk features (submucosal infiltration\>1000 um, invasion of lymphatic vessels, poor differentiation (G3))
  • Lesions in the upper GI tract
  • Patients with colorectal stenosis
  • Patinets not able to undergo informed consent
  • Pregnancy
  • Patients with urgent indication for dual thrombocyte aggregation inhibition

Outcomes

Primary Outcomes

Technical success

Time Frame: Immediate

Successful enbloc- and macroscopically complete resection

R0-Resection

Time Frame: 3 days

Histologically confirmed complete resection

Secondary Outcomes

  • Necessity of surgical treatment(3 months)
  • Residual or recurrent adenoma/carcinoma at endoscopic follow up(3 months)
  • Histologically confirmed full thickness resection(3 days)
  • Procedure-associated complications(3 months)
  • Procedure time(immediate)

Study Sites (1)

Loading locations...

Similar Trials